Autores: Marchesini Giulio, Marchignoli Francesca, Petta Salvatore
Healthy controls are subjects without the disease being studied but may have other conditions indirectly affecting outcome. In the present epidemics of obesity a few subjects with undiagnosed nonalcoholic fatty liver disease enter clinical studies as controls, producing biased results. Stricter selection criteria should be considered to prevent this risk.
Palabras clave: Clinical trials control group liver enzymes nafld obesity.
2017-12-13 | 354 visitas | Evalua este artículo 0 valoraciones
Vol. 16 Núm.6. Noviembre-Diciembre 2017 Pags. 832-834 Ann Hepatol 2017; 16(6)